1-11 of 11
Payal Kapur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans

Yuanqing Ma, Allison Joyce, Olivia Brandenburg, Faeze Saatchi, Christina Stevens, Vanina Toffessi Tcheuyap, Alana Christie, Quyen N. Do, Oluwatomilade Fatunde, Alyssa Macchiaroli, So C. Wong, Layton Woolford, Qurratulain Yousuf, Jeffrey Miyata, Deyssy Carrillo, Oreoluwa Onabolu, Tiffani McKenzie, Akhilesh Mishra, Tanner Hardy, Wei He, Daniel Li, Alexander Ivanishev, Qing Zhang, Ivan Pedrosa, Payal Kapur, Thomas Schluep, Steven B. Kanner, James Hamilton, James Brugarolas
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5405–5418.
https://doi.org/10.1158/1078-0432.CCR-22-0963
Published: 15 December 2022
View article titled, HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
Open the PDF for HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans in another window
Includes: Supplementary data
Journal Articles

ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma

Aditi Mulgaonkar, Roy Elias, Layton Woolford, Bing Guan, Kien Nham, Payal Kapur, Alana Christie, Vanina T. Tcheuyap, Nirmish Singla, I. Alex Bowman, Christina Stevens, Guiyang Hao, James Brugarolas, Xiankai Sun
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4907–4916.
https://doi.org/10.1158/1078-0432.CCR-22-1547
Published: 14 November 2022
View article titled, ImmunoPET Imaging with <sup>89</sup>Zr-Labeled Atezolizumab Enables <em>In Vivo</em> Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Open the PDF for ImmunoPET Imaging with <sup>89</sup>Zr-Labeled Atezolizumab Enables <em>In Vivo</em> Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit

Toni K. Choueiri, Laurence Albiges, Michael B. Atkins, Ziad Bakouny, Gennady Bratslavsky, David A. Braun, Naomi B. Haas, John B.A.G. Haanen, A. Ari Hakimi, Michael A.S. Jewett, Eric Jonasch, William G. Kaelin, Jr, Payal Kapur, Chris Labaki, Bryan Lewis, David F. McDermott, Sumanta K. Pal, Kevin Pels, Susan Poteat, Thomas Powles, W. Kimryn Rathmell, Brian I. Rini, Sabina Signoretti, Nizar M. Tannir, Robert G. Uzzo, Hans J. Hammers
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 831–839.
https://doi.org/10.1158/1078-0432.CCR-21-3238
Published: 03 March 2022
View article titled, From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit
Open the PDF for From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit in another window
Journal Articles

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

Raquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, Subrata Manna, Laurentiu M. Pop, Ze Zhang, Samantha Mannala, Alana Christie, Scott Christley, Nancy Monson, Dan Ishihara, Eric J. Hsu, Chul Ahn, Payal Kapur, Mingyi Chen, Yull Arriaga, Kevin Courtney, Brandi Cantarel, Edward K. Wakeland, Yang-Xin Fu, Ivan Pedrosa, Lindsay Cowell, Tao Wang, Vitaly Margulis, Hak Choy, Robert D. Timmerman, James Brugarolas
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (24): 6716–6725.
https://doi.org/10.1158/1078-0432.CCR-21-2083
Published: 15 December 2021
View article titled, Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma
Open the PDF for Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform

Durga Udayakumar, Ze Zhang, Yin Xi, Durgesh K. Dwivedi, Michael Fulkerson, Sydney Haldeman, Tiffani McKenzie, Qurratulain Yousuf, Allison Joyce, Asghar Hajibeigi, Hollis Notgrass, Alberto Diaz de Leon, Qing Yuan, Matthew A. Lewis, Ananth J. Madhuranthakam, Robert C. Sibley, Roy Elias, Junyu Guo, Alana Christie, Renée M. McKay, Jeffrey A. Cadeddu, Aditya Bagrodia, Vitaly Margulis, James Brugarolas, Tao Wang, Payal Kapur, Ivan Pedrosa
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (17): 4794–4806.
https://doi.org/10.1158/1078-0432.CCR-21-0706
Published: 01 September 2021
View article titled, Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform
Open the PDF for Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform in another window
Includes: Supplementary data
Journal Articles

Abstract B21: PTRF promotes cell survival and predicts disease progression in upper tract urothelial carcinoma

Hsin-Chih Yeh, Nirmish Singla, Elizabeth Hernandez, Vandana Panwar, Vitaly Margulis, Payal Kapur, Shahrokh F. Shariat, Wen-Jeng Wu, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): B21.
https://doi.org/10.1158/1557-3265.BLADDER19-B21
Published: 03 August 2020
View article titled, Abstract B21: PTRF promotes cell survival and predicts disease progression in upper tract urothelial carcinoma
Journal Articles

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie, Layton Woolford, Nirmish Singla, Allison Joyce, Haley Hill, Ananth J. Madhuranthakam, Qing Yuan, Yin Xi, Yue Zhang, Jenny Chang, Oluwatomilade Fatunde, Yull Arriaga, Arthur E. Frankel, Sanjeeva Kalva, Song Zhang, Tiffani McKenzie, Oscar Reig Torras, Robert A. Figlin, Brian I. Rini, Renée M. McKay, Payal Kapur, Tao Wang, Ivan Pedrosa, James Brugarolas
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 793–803.
https://doi.org/10.1158/1078-0432.CCR-19-1459
Published: 14 February 2020
View article titled, HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Open the PDF for HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation

Eun-Jin Yun, Chun-Jung Lin, Andrew Dang, Elizabeth Hernandez, Jiaming Guo, Wei-Min Chen, Joyce Allison, Nathan Kim, Payal Kapur, James Brugarolas, Kaijie Wu, Dalin He, Chih-Ho Lai, Ho Lin, Debabrata Saha, Seung Tae Baek, Benjamin P.C. Chen, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (14): 4542–4551.
https://doi.org/10.1158/1078-0432.CCR-18-3004
Published: 15 July 2019
View article titled, Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation
Open the PDF for Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation in another window
Includes: Supplementary data
Journal Articles

Abstract IA10: Renal cancer tumorgrafts: A validated model to evaluate novel targeted therapies

Andrea Pavia-Jimenez, Wenfang Chen, Haley Hill, Alana Christie, Qurratulain Yousuf, Noelle Williams, Xian-Jin Xie, Payal Kapur, James Brugarolas
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): IA10.
https://doi.org/10.1158/1557-3265.PDX16-IA10
Published: 15 August 2016
View article titled, Abstract IA10: Renal cancer tumorgrafts: A validated model to evaluate novel targeted therapies
Journal Articles

Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors

Jeanette E. Eckel-Passow, Daniel J. Serie, John C. Cheville, Thai H. Ho, Sue M. Harrington, Tracy Hilton, Christine Lohse, Amanda Shreders, Payal Kapur, James Brugarolas, R Houston Thompson, Bradley C. Leibovich, Eugene D. Kwon, Richard W. Joseph, Alexander S. Parker
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): 10.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-10
Published: 03 January 2016
View article titled, Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors
Journal Articles

Abstract A36: Unveiling biomarker and mechanism of drug resistance to molecular targeted therapeutics in renal cell carcinoma

Jiancheng Zhou, Kaijie Wu, Eunjin Yun, Payal Kapur, Rey-Chen Pong, Dalin He, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4_Supplement): A36.
https://doi.org/10.1158/1557-3265.PMS14-A36
Published: 13 February 2015
View article titled, Abstract A36: Unveiling biomarker and mechanism of drug resistance to molecular targeted therapeutics in renal cell carcinoma